{"acute hepatic failure": 11.18, "acute hepatitis b": 18.1, "acute lung injury": 32.3, "acute myeloid leukaemia": 5.98, "acute respiratory distress syndrome": 3.89, "adenovirus infection": 5.17, "adjustment disorder with depressed mood": 7.55, "agranulocytosis": 11.02, "anti-cyclic citrullinated peptide antibody positive": 22.38, "arthropathy": 6.38, "aspergillus infection": 5.8, "autoimmune haemolytic anaemia": 5.17, "b-cell lymphoma": 5.96, "b-cell lymphoma recurrent": 68.91, "b-lymphocyte count decreased": 16.3, "back injury": 3.13, "bacteraemia": 7.64, "bacterial infection": 2.56, "bacterial sepsis": 5.64, "basal cell carcinoma": 2.48, "bicytopenia": 14.04, "blepharospasm": 2.45, "blister": 2.18, "blood cholesterol increased": 4.01, "blood lactate dehydrogenase increased": 3.77, "blood pressure diastolic abnormal": 174.63, "blood pressure diastolic decreased": 30.95, "blood pressure diastolic increased": 33.72, "blood pressure fluctuation": 12.21, "blood pressure increased": 2.01, "blood pressure systolic abnormal": 220.93, "blood pressure systolic increased": 26.31, "body temperature decreased": 6.1, "bone marrow failure": 3.81, "breast cancer stage iii": 19.3, "bronchiectasis": 3.58, "bronchopulmonary aspergillosis": 5.1, "bursitis": 5.02, "c-reactive protein abnormal": 5.69, "c-reactive protein increased": 2.75, "candida infection": 2.86, "cardiomyopathy": 3.01, "cardiotoxicity": 4.64, "castleman's disease": 32.82, "central nervous system lymphoma": 24.69, "cerebral disorder": 2.44, "cervix disorder": 30.01, "chronic lymphocytic leukaemia": 22.64, "chronic lymphocytic leukaemia recurrent": 34.76, "clostridium difficile colitis": 4.01, "coeliac disease": 6.9, "contraindicated product administered": 7.18, "covid-19 pneumonia": 7.03, "cutaneous vasculitis": 2.27, "cytomegalovirus chorioretinitis": 15.47, "cytomegalovirus infection": 5.17, "cytomegalovirus infection reactivation": 3.15, "cytomegalovirus viraemia": 6.86, "cytopenia": 7.49, "device related infection": 2.1, "diffuse large b-cell lymphoma": 28.15, "diffuse large b-cell lymphoma recurrent": 70.57, "diffuse large b-cell lymphoma refractory": 52.5, "diffuse large b-cell lymphoma stage iv": 57.6, "dilated cardiomyopathy": 2.18, "disease progression": 5.11, "disease recurrence": 2.12, "dislocation of vertebra": 16.69, "disseminated bacillus calmette-guerin infection": 39.53, "drug hypersensitivity": 5.72, "drug ineffective for unapproved indication": 2.49, "drug intolerance": 4.24, "drug resistance": 2.02, "duodenal ulcer perforation": 27.21, "ear infection": 2.02, "ear pruritus": 9.26, "ejection fraction decreased": 2.74, "endocarditis": 3.03, "epstein-barr virus infection": 4.17, "eye infection": 2.73, "facet joint syndrome": 13.33, "febrile neutropenia": 18.19, "fibromyalgia": 3.59, "finger deformity": 11.85, "foetal exposure during pregnancy": 2.4, "follicular lymphoma": 41.95, "folliculitis": 9.37, "foot deformity": 3.09, "glossodynia": 6.65, "granulocyte count decreased": 22.93, "granulocytopenia": 8.37, "grip strength decreased": 3.04, "haematotoxicity": 6.84, "hand deformity": 13.55, "heart rate decreased": 8.22, "helicobacter infection": 17.6, "hepatic encephalopathy": 2.05, "hepatic enzyme increased": 3.1, "hepatic failure": 2.68, "hepatitis b": 20.45, "hepatitis b reactivation": 87.59, "herpes simplex": 2.85, "hodgkin's disease": 12.57, "humoral immune defect": 257.16, "hypoalbuminaemia": 4.16, "hypogammaglobulinaemia": 24.97, "ill-defined disorder": 7.2, "immune reconstitution inflammatory syndrome": 2.29, "immunodeficiency": 4.07, "immunosuppression": 4.57, "impaired healing": 4.99, "infection": 4.34, "infusion related reaction": 14.47, "intentional product use issue": 4.41, "interstitial lung disease": 6.98, "intestinal perforation": 4.5, "irritable bowel syndrome": 4.25, "jc virus infection": 23.98, "joint range of motion decreased": 2.35, "joint swelling": 3.64, "klebsiella infection": 5.69, "klebsiella sepsis": 15.02, "left ventricular dysfunction": 2.54, "leukopenia": 4.33, "liver injury": 3.84, "localised infection": 2.49, "low birth weight baby": 4.22, "lower respiratory tract infection": 3.08, "lymphocyte count decreased": 5.47, "lymphocytosis": 6.52, "lymphoma": 4.24, "lymphopenia": 4.57, "lymphoproliferative disorder": 6.5, "mantle cell lymphoma": 14.37, "mantle cell lymphoma recurrent": 37.15, "maternal exposure during pregnancy": 2.43, "maternal exposure timing unspecified": 4.72, "metastasis": 2.47, "mucosal inflammation": 3.21, "multiple organ dysfunction syndrome": 2.04, "muscle injury": 7.36, "myelodysplastic syndrome": 6.28, "myelosuppression": 14.59, "nasopharyngitis": 2.54, "neutropenia": 7.53, "neutropenic sepsis": 24.34, "neutrophil count decreased": 9.43, "neutrophil count increased": 3.2, "nodule": 3.19, "non-hodgkin's lymphoma": 8.12, "non-hodgkin's lymphoma recurrent": 63.0, "oesophageal candidiasis": 4.38, "off label use": 2.47, "onychomycosis": 7.13, "oxygen saturation decreased": 6.73, "pancytopenia": 5.65, "pemphigus": 7.65, "platelet count decreased": 2.13, "pneumocystis jirovecii pneumonia": 36.65, "pneumonia": 3.49, "pneumonia bacterial": 3.43, "pneumonia cytomegaloviral": 6.9, "pneumonia fungal": 4.55, "poor venous access": 10.64, "post transplant lymphoproliferative disorder": 6.91, "posterior reversible encephalopathy syndrome": 3.95, "premature baby": 3.32, "premature delivery": 2.79, "product use in unapproved indication": 3.68, "productive cough": 2.37, "progressive multifocal leukoencephalopathy": 22.23, "pseudomonas infection": 4.55, "pulmonary alveolar haemorrhage": 3.17, "pulmonary fibrosis": 2.93, "pulmonary toxicity": 19.49, "recurrent cancer": 11.98, "red blood cell sedimentation rate increased": 2.35, "remission not achieved": 169.94, "respiratory failure": 2.8, "respiratory rate increased": 2.16, "rheumatic fever": 10.08, "rheumatoid arthritis": 3.31, "rheumatoid factor positive": 9.05, "richter's syndrome": 41.98, "second primary malignancy": 7.22, "sepsis": 3.62, "septic shock": 4.97, "sinusitis": 2.85, "skin infection": 2.26, "skin laceration": 2.61, "staphylococcal bacteraemia": 4.52, "staphylococcal sepsis": 4.75, "stomatitis": 2.02, "synovitis": 6.29, "systemic lupus erythematosus": 2.0, "therapeutic product effect decreased": 2.29, "therapeutic response decreased": 2.28, "therapy non-responder": 3.24, "therapy partial responder": 9.99, "throat irritation": 2.3, "thrombocytopenia": 3.09, "tooth disorder": 2.37, "tooth infection": 5.13, "traumatic lung injury": 10.64, "treatment failure": 3.07, "tumour lysis syndrome": 20.99, "upper respiratory tract infection": 2.31, "urosepsis": 2.18, "varicella": 3.54, "varicella zoster virus infection": 5.09, "weight increased": 2.07, "white blood cell count decreased": 8.01, "wound": 2.63}